Processing the protocol with id 153
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
This part was defined, probably, at this section: 2.2 AMG 162 Background 
For more information about the rationales, go to sections:
2.3 Rationale 
I have not found anything about the previous studies from titles, lets take a look for the introduction
Previous studies: FOUND
Occurrences in the text:
13701	Phase 2 	"... women.  d e v o r p p A In a Phase 2 study, the treatment effect of..."
24521	Phase II 	"... in a rapid change in BMD in the Phase II clinical trial. Due to  this..."
11280	phase 2 	"... that have been completed and a  phase 2 study that has completed 24..."
12742	phase 2 	"... antibodies.  Interim results from a phase 2 study in postmenopausal women..."
11232	phase 1 	"...  Safety data available from five phase 1 studies that have been..."
12078	clinical studies with	"... in some  subjects participating in clinical studies with AMG 162. In most..."
22762	phase II  	"... therefore we anticipate, based on the phase II  clinical trial that..."
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 2.4 Clinical Hypothesis 
Primary objectives: NOT FOUND
Secondary objectives: NOT FOUND
Objectives: NOT FOUND
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "4a Eligibility criteria for participants..."
This part was defined, probably, at this section: 4. SUBJECT ELIGIBILITY 
I have found: exclusion criteria, inclusion criteria
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
This part was defined, probably, at this section: 7. STUDY PROCEDURES 
##########################################
Checking for the item “7a how sample size was determined”...
This part was defined, probably, at this section: 10.3 Sample Size Considerations 
##########################################
Searching any information about a randomzation
This part was defined, probably, at this section: 5.2 Randomization 
Maybe this information will be interesting:
26752	will be randomized	"... e study.  Upon meeting all eligibility criteria and completing all screening assessments, subjects  will be randomized 1:1 to one of 2 treatment arms (n=104/arm):  (cid:120) 60 mg AMG 162 SC every 6..."
28972	will be randomized	"... red to as subjects . Approximately  208 subjects will be enrolled into the study. Eligible subjects will be randomized to one of  the 2 treatment groups.  d e v o r p p A On average, approximately 10..."
38153	will be randomized	"... on a double blind randomization  schedule prepared by Amgen before the start of the study. Subjects will be randomized  using a 1:1 allocation to one of 2 treatment groups as outlined in Table 1, and..."
41378	will be randomized	"... armacokinetic profiles.  6.2 Investigational Product Dosage, Administration, and Schedule  Subjects will be randomized 1:1 to receive 60 mg of AMG 162 or placebo every 6  months. All subjects will..."
134419	will be randomized	"... olution containing no drug.  j.  Who decides if I get the test drug product or something else?  You will be randomized by chance to receive investigational product or placebo. Your  doctor will not..."
139173	will be randomized	"... lacebo (a solution containing no  active drug); or 60 mg AMG 162. If you qualify for the study, you will be randomized into  one of the treatment groups just described for 24 months.  All subjects..."
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
This part was defined, probably, at this section: 13.3 Study Monitoring and Data Collection 
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
I found the following methods:
85845 	  cox  	 "... ween AMG 162  and placebo groups using a Cox semi parametric model (Lawless,..."
86835 	  cox  	 "... tween AMG 162 and placebo groups using a Cox semi parametric model (Lawless, ..."
201895 	  cox  	 "... ween AMG 162 and placebo  groups using a Cox semi parametric model (Lawless,..."
202812 	  cox  	 "... tween AMG 162 and placebo groups using a Cox semi parametric model (Lawless, ..."
199990 	 cochran mantel haenszel 	 "... ompared between treatment  groups using Cochran Mantel Haenszel two sided tests..."
86309 	 kaplan meier 	 "... onfidence intervals for the median, and Kaplan Meier event  rates at the time..."
86364 	 kaplan meier 	 "... ent  rates at the time of analysis. The Kaplan Meier graphs will also be..."
87404 	 kaplan meier 	 "... onfidence intervals for the median, and Kaplan Meier event  rates at month 24..."
87487 	 kaplan meier 	 "... wo tailed 95% confidence intervals. The Kaplan Meier  graphs will also be..."
202337 	 kaplan meier 	 "... nfidence intervals for  the median, and Kaplan Meier event rates at the time of..."
202391 	 kaplan meier 	 "... vent rates at the time of analysis. The Kaplan Meier  graphs will also be..."
203257 	 kaplan meier 	 "... onfidence intervals for the median, and Kaplan Meier event  rates at month 24..."
203340 	 kaplan meier 	 "... wo tailed 95% confidence intervals. The Kaplan Meier  graphs will also be..."
